Cargando…

Beta blockers versus calcium channel blockers for provocation of vasospastic angina after drug-eluting stent implantation: a multicentre prospective randomised trial

BACKGROUND: Drug-eluting stent-induced vasospastic angina (DES-VSA) has emerged as a novel complication in the modern era of percutaneous coronary intervention (PCI). Although beta blockers (BBs) are generally recommended for coronary heart disease, they may promote incidence of DES-VSA. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawano, Mitsuaki, Katsuki, Toshiomi, Kitai, Takeshi, Tamita, Koichi, Obunai, Kotaro, Ikegami, Yukinori, Yamane, Takafumi, Ueda, Ikuko, Endo, Ayaka, Maekawa, Yuichiro, Kawamura, Akio, Fukuda, Keiichi, Kohsaka, Shun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Coronary Artery Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580072/ https://www.ncbi.nlm.nih.gov/pubmed/33087441 http://dx.doi.org/10.1136/openhrt-2020-001406

Ejemplares similares

Comparison of various calcium antagonist on vasospastic angina: a systematic review
por: Singh, Jaspal, et al.
Publicado: (2023)

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
por: Ishak, Divan, et al.
Publicado: (2023)

Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial
por: Fabris, Enrico, et al.
Publicado: (2020)

A new perspective on calcium channel blockers in vasospastic angina
por: Kim, Hack-Lyoung
Publicado: (2021)

Provocative biomarker stress test: stress-delta N-terminal pro-B type natriuretic peptide
por: Limkakeng Jr, Alexander T, et al.
Publicado: (2018)

Interpreting angina: symptoms along a gender continuum
por: Kreatsoulas, Catherine, et al.
Publicado: (2016)

Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent
por: Barkholt, Trine Ø., et al.
Publicado: (2019)

Ergonovine Provocation Echocardiography for Detection and Prognostication in Patients with Vasospastic Angina
por: Park, Jae-Hyeong
Publicado: (2018)

The relationship between re-endothelialization and endothelial function after DES implantation: Comparison between paclitaxcel eluting stent and zotarolims eluting stent
por: Murase, Suguru, et al.
Publicado: (2014)

One‐year clinical outcomes of patients treated with polymer‐free amphilimus‐eluting stents or zotarolimus‐eluting stents: A propensity‐score adjusted analysis
por: Rozemeijer, Rik, et al.
Publicado: (2019)

Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds
por: Schukraft, Sara, et al.
Publicado: (2021)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Role of ivabradine in management of stable angina in patients with different clinical profiles
por: Kaski, Juan Carlos, et al.
Publicado: (2018)

Prevalence of angina pectoris and association with coronary atherosclerosis in a general population
por: Welén Schef, Kerstin, et al.
Publicado: (2023)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Comparison of calcium-channel blockers for long-term clinical outcomes in patients with vasospastic angina
por: Kim, Sung Eun, et al.
Publicado: (2021)

Vasospastic Angina Diagnosed by the Spasm Provocation Test with the Combined Use of the Acetylcholine and Ergonovine Provocation Tests
por: Matsumura, Mirai, et al.
Publicado: (2019)

Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent
por: Toelg, Ralph, et al.
Publicado: (2020)

Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
por: Kim, Soo‐Hyun, et al.
Publicado: (2019)

Pre-test characteristics of unstable angina patients with obstructive coronary artery disease confirmed by coronary angiography
por: Fladseth, Kristina, et al.
Publicado: (2018)

A 10-year prognostic model for patients with suspected angina attending a chest pain clinic
por: Sekhri, Neha, et al.
Publicado: (2016)

Long-term impact of baseline anaemia on clinical outcomes following percutaneous coronary intervention in stable angina
por: Davidsen, Line, et al.
Publicado: (2020)

Comparison of neointimal coverage between ultrathin biodegradable polymer‐coated sirolimus‐eluting stents and durable polymer‐coated everolimus‐eluting stents: 6 months optical coherence tomography follow‐up from the TAXCO study
por: Abhyankar, Atul, et al.
Publicado: (2020)

Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial
por: Williams, Michelle C, et al.
Publicado: (2017)

Succinobucol-Eluting Stents Increase Neointimal Thickening and Peri-Strut Inflammation in a Porcine Coronary Model
por: Watt, Jonathan, et al.
Publicado: (2013)

Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial
por: Iñiguez, Andrés, et al.
Publicado: (2019)

Comparison of 6‐month vascular healing response after bioresorbable polymer versus durable polymer drug‐eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study
por: Noguchi, Masahiko, et al.
Publicado: (2021)

Safety and efficacy of Everolimus‐Eluting bioabsorbable Polymer‐Coated stent in patients with long coronary lesions: The EVOLVE 48 study
por: Karmpaliotis, Dimitrios, et al.
Publicado: (2021)

Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials
por: Jackson-Smith, Elliot, et al.
Publicado: (2022)

Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial
por: Hennigan, Barry, et al.
Publicado: (2020)

Biological effect on drug distribution and vascular healing via paclitaxel‐coated balloon technology in drug eluting stent restenosis swine model
por: Li, Yan, et al.
Publicado: (2015)

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
por: Buiten, Rosaly A., et al.
Publicado: (2020)

Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020)

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention
por: Krenn, Lisa, et al.
Publicado: (2014)

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
por: Ploumen, Eline H., et al.
Publicado: (2019)

Usefulness of scoring system for diagnosis of vasospastic angina – Is spasm provocation test no longer needed?
por: Aoki, Tatsuo
Publicado: (2019)

Cost‐effectiveness of percutaneous coronary intervention with cobalt‐chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta‐analysis of randomized trials
por: Ferko, Nicole, et al.
Publicado: (2016)

Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials
por: Bjerking, Louise Hougesen, et al.
Publicado: (2019)

Patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris randomised to an invasive versus conservative strategy: angiographic and procedural results from the After Eighty study
por: Tegn, Nicolai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7s2ou0p6p5va3lbu62rj2behkl